Potential Anti-Atherosclerotic Properties of Astaxanthin - Wikidata - wikimedia - TriplyDB

Potential Anti-Atherosclerotic Properties of Astaxanthin

Potential Anti-Atherosclerotic Properties of Astaxanthin

http://www.wikidata.org/entity/Q26767224

about

Preventive effect of dietary astaxanthin on UVA-induced skin photoaging in hairless mice Astaxanthin protects against early burn-wound progression in rats by attenuating oxidative stress-induced inflammation and mitochondria-related apoptosis.Astaxanthin ameliorates ferric nitrilotriacetate-induced renal oxidative injury in rats.The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis.Lobster processing by-products as valuable bioresource of marine functional ingredients, nutraceuticals, and pharmaceuticals.In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.Effects of Astaxanthin on Reverse Cholesterol Transport and Atherosclerosis in Mice.Mechanisms of foam cell formation in atherosclerosis.Reverse Cholesterol Transport: Molecular Mechanisms and the Non-medical Approach to Enhance HDL Cholesterol.

P2860

Q36272955-B46FC507-487A-4976-A0BB-D3A4E7A73644 Q37609585-32289C5F-6CB1-4CA1-812A-CE19F974A5FF Q38656388-281F0AD4-99C9-452D-A94A-29702F6171AA Q38878978-0FC7F138-4CFC-490E-BFD6-4F4FA061B4DF Q39416830-A9035732-2563-47AB-8398-987234FAF50C Q39486132-BB2E2193-3B74-4318-9340-54D8A59894F5 Q47093568-AE19433C-C9D2-4F70-ABB3-E84D0DB1A18B Q52759762-6A2E958A-68C9-475C-BE0E-85A92AB9DF1C Q55004470-0C33BA30-4939-4315-8CB4-4B22293BE261

P2860

Potential Anti-Atherosclerotic Properties of Astaxanthin

http://www.wikidata.org/entity/Q26767224

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Potential Anti-Atherosclerotic Properties of Astaxanthin

@ast

Potential Anti-Atherosclerotic Properties of Astaxanthin

@en

Potential Anti-Atherosclerotic Properties of Astaxanthin

@nl

type

label

Potential Anti-Atherosclerotic Properties of Astaxanthin

@ast

Potential Anti-Atherosclerotic Properties of Astaxanthin

@en

Potential Anti-Atherosclerotic Properties of Astaxanthin

@nl

prefLabel

Potential Anti-Atherosclerotic Properties of Astaxanthin

@ast

Potential Anti-Atherosclerotic Properties of Astaxanthin

@en

Potential Anti-Atherosclerotic Properties of Astaxanthin

@nl

P1433

Q26767224-B7662ED9-41AC-4E07-894F-8085E11FBD8E

P1476

Q26767224-7CA73E8D-6BB8-4B08-AEC3-FA6B5DE0D890

P2093

Q26767224-1E7D4905-801D-45D7-AD0C-56F7C2B4A8D6

Q26767224-75BA315F-39DC-49F8-BAD6-D86975B2A97D

P275

Q26767224-E27D55B5-1023-43DC-A25C-1027B58AC795

P2860

Q26767224-002371BD-EDFC-44E0-BFF4-D1E445A11983

Q26767224-026C58FA-B3DD-47B3-8064-0CA5E16AE896

Q26767224-0758E83A-5AA1-4DBC-80E1-00782CF9F03B

Q26767224-0AB43CD1-B0AB-442E-9876-FF96199ADBA6

Q26767224-0B65A55F-885D-45B2-A719-4ADD7EFBB9A4

Q26767224-0F7356C4-6500-4DA0-BDD2-17490A1FD20A

Q26767224-112B2521-7EFB-4149-8127-CF194F824BA7

Q26767224-13F6FDE1-D17E-4B58-90E8-F1E256E696C6

Q26767224-16DA1061-983C-41E4-AFD6-CC8095D8FDFA

Q26767224-19785BD1-C113-41E9-AFFE-D0CD91942072

P304

Q26767224-4E6AD216-5228-4928-A6AA-EE46E6D3AF4F

P31

Q26767224-68B31A6F-B5D7-4F8F-90EF-CD2DD9CB1804

Q26767224-F8C42E69-9B31-47A1-8099-F1F41812298F

P356

Q26767224-9B4BE2B7-FD6E-4404-AB3C-4AFCFA1683C2

P407

Q26767224-530993CE-CB32-46F1-A1A0-9B24B11B448F

P433

Q26767224-68061464-61E8-4541-BECA-BB41E2E947EF

P478

Q26767224-17081532-966E-48DE-B54F-D0FA021ACC29

P50

Q26767224-7D60A355-2C2D-4132-B067-0BCCAC4FC1E2

P5008

Q26767224-FCBE1A96-5561-4E0E-908E-E8F9CC21EB0D

P577

Q26767224-73EB2D3D-B57C-43FC-8948-8D025C8BAAB9

Q26767224-A1F5CABC-C2AC-443F-B9EB-8ACEA1595A31

P5875

Q26767224-3828C6A9-45A2-46DE-A319-AE5E57A723E6

P698

Q26767224-C4DA3FBE-F97F-4BB6-9E0A-6FDE9E9FA9C2

P921

Q26767224-2ED19D2E-88BA-48E3-83E5-4B49428A7ECE

Q26767224-40BB8746-D218-4020-8E7B-82AD93172F39

Q26767224-78BDF2B4-BC48-4C35-B518-182209CFDD0F

Q26767224-B93B739C-AE8D-4999-BB86-73FE7C2055FD

P932

Q26767224-807BC908-F58B-40B6-8D28-A56B2AF8037E

P356

P1433

P1476

Potential Anti-Atherosclerotic Properties of Astaxanthin

@en

P2093

Hiroshi Yoshida

http://www.w3.org/2001/XMLSchema#string

Kazuo Kondo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages

Astaxanthin in cardiovascular health and disease

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements

Astaxanthin and omega-3 fatty acids individually and in combination protect against oxidative stress via the Nrf2-ARE pathway

Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation

The complexity of the Nrf2 pathway: beyond the antioxidant response

Increased oxidative stress in obesity and its impact on metabolic syndrome

Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals

Astaxanthin reduces ischemic brain injury in adult rats.

P304

35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MD14020035

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Yoshimi Kishimoto

P5008

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

293191848

http://www.w3.org/2001/XMLSchema#string

P698

26861359

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

mechanism of action

P932

4771988

http://www.w3.org/2001/XMLSchema#string